FDA Approves New Pill for Postpartum Depression : vimarsana.

The FDA just approved zuranolone, a new medication to treat postpartum depression. The drug is in pill form and meant to be taken once a day for 14 days for fast-acting treatment.

Related Keywords

United States , Laura Gault , Christopher Zahn , Elizabethm Fitelson , Health Equity , Columbia University Department Of Psychiatry , Sage Therapeutics Inc , Biogen Inc , Drug Administration , Women Program , American College Of Obstetrics , Sage Therapeutics , Clinical Practice , American College , Novel Approach , Depression Treatment , Columbia University Department , Long Acting Treatment , Huge Step , Postpartum Medicine , Could Be Available ,